Contrast Enhanced Ultrasound Market By Products (Equipment and Contrast Agent), By Types (Non-targeted and Targeted), By End-users (Hospitals, Clinics, Ambulatory Diagnostic Centers) and By Regions (North America, Europe, Asia Pacific, Latin America, and Middle East & Africa) Global Industry Analysis, Growth, Share, Size, Trends, and Forecast 2023-2031
Contrast Enhanced Ultrasound Market 2031:
The global contrast enhanced ultrasound market size was valued at USD 1.95 Billion in 2022 and is expected to reach USD 2.82 Billion by 2031, expanding at a CAGR of 4.2% during the forecast period, 2023-2031.
Factors such as introduction of cost-effective contrast agents, increasing demand for contrast imaging modes in ultrasound systems, and increasing ultrasound procedure volume for diagnosis of various diseases is anticipated to boost the market.
Contrast-enhanced ultrasound is defined as a technique that employs specialized imaging techniques and microbubble contrast agents. The technique is used to represent information regarding tissue perfusion and blood flow.
CEUS is safe and is performed easily. The technique does not require ionizing radiation and has no risk of nephrotoxicity. Contrast enhanced ultrasound is abbreviated as CEUS. CEUS is more radiation-free, cost-efficient, and patient-friendly as compared to other technologies. These factors are expected to propel the market.
Contrast enhanced ultrasound is employed, due to the advantages offered such as early diagnosis of COVID-19-related pneumonia. Rapid rise in the number of ultrasonography procedures related to lungs is expected to boost the demand for this process, which in turn, is projected to drive the market. Moreover, the rising incidence of gastrointestinal and cardiovascular diseases is estimated to boost the demand for contrast enhanced ultrasound in the near future.
The emergence of COVID-19 has positively affected the market, owing to the involvement of contrast enhanced ultrasound in one of the preferred grading systems for assessment of lung deterioration in COVID-19 patients. CEUS aids in identification of lung damage during the asymptomatic phase of the COVID-19.
Moreover, it is used as a bedside imaging tool to measure perfusion impairment in kidney, lung, and brain of pediatric COVID-19 patients. Considerable number of studies to detect the presence of microthrombi in COVID-19 patients is anticipated to increase the applications of CEUS and boost the usage of these devices in the near future.
Contrast Enhanced Ultrasound Market Trends, Drivers, Restraints, and Opportunities
- Contrast enhanced ultrasound is used for imaging blood perfusion in organs, which drives the market.
- Applications such as measurement of blood flow rate in the heart and other organs is anticipated to boost the market in the near future.
- Supply chain disruptions and stringent protocols such as 50% capacity in facilities is projected to hamper the market growth.
- Technological advancements and innovations are anticipated to create lucrative opportunities for the players in the market.
Scope of Contrast Enhanced Ultrasound Market Report
The report on the global contrast enhanced ultrasound market includes an assessment of the market, size, share, trends, segments, and regional markets. Overview and dynamics have been included in the report.
Attributes |
Details |
Report Title |
Contrast Enhanced Ultrasound Market - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast |
Base Year |
2022 |
Historic Data |
2016-2021 |
Forecast Period |
2023–2031 |
Segmentation |
Products (Equipment and Contrast Agent), Types (Non-targeted and Targeted), End-users (Hospitals, Clinics, Ambulatory Diagnostic Centers) |
Regional Scope |
Asia Pacific, North America, Europe, Latin America, and Middle East & Africa |
Report Coverage |
Market scope, analysis, share, competitive analysis, growth facts, restraints, opportunities, and revenue forecast |
Key Players Covered in the Report |
Siemens Healthcare Private Limited, Trivitron Healthcare, BK Medical Holding Company, Inc., General Electric Company, Bracco Diagnostic Inc., Bristol–Myers Squibb, and Sonus Pharmaceuticals |
Contrast Enhanced Ultrasound Market Segment Insights
Products Segment Analysis
Based on products, the market is bifurcated into equipment and contrast agent. The contrast agent segment is anticipated to grow at a rapid pace, owing to its adoption and rising demand. The introduction of advanced ultrasound units with transducer technology and nonlinear imaging techniques simplified the workflow of CEUS, thereby fueling the segmental share for equipment.
Types Segment Analysis
On the basis of types, the market is categorized into non-targeted and targeted. The ultrasound contrast agents used in contrast enhanced ultrasound are non-targeted. They are mostly employed to enhance diagnostic sensitivity and precision for determination of the blood volume and flow to help in differentiation between benign liver tumors and malignant. The non-targeted contrast agent segment is anticipated to hold the largest market share in 2020, owing to availability of commercial products of this type.
End-Users Segment Analysis
In terms of end-users, the market is fragmented into hospitals, clinics, and ambulatory diagnostic centers. The ambulatory diagnostic centers segment is expected to hold a large share of the market during the forecast period, owing to emergency services offered during COVID-19.
Regional Analysis
Based on regions, the contrast enhanced ultrasound market is segmented into North America, Europe, Asia Pacific, Latin America, and Middle East & Africa. The market in North America is expected to register substantial CAGR during the forecast period. Growth of the market in the region is attributed to research and development activities in contrast enhanced ultrasound in North America.
2. Assumptions and Acronyms Used
3. Research Methodology
4. Contrast Enhanced Ultrasound Market Overview
4.1. Introduction
4.1.1. Market Taxonomy
4.1.2. Market Definition
4.2. Macro-Economic Factors
4.2.1. Industry Outlook
4.3. Contrast Enhanced Ultrasound Market Dynamics
4.3.1. Market Drivers
4.3.2. Market Restraints
4.3.3. Opportunity
4.3.4. Market Trends
4.4. Contrast Enhanced Ultrasound Market - Supply Chain
4.5. Global Contrast Enhanced Ultrasound Market Forecast
4.5.1. Contrast Enhanced Ultrasound Market Size (US$ Mn) and Y-o-Y Growth
4.5.2. Contrast Enhanced Ultrasound Market Size (000’ Units) and Y-o-Y Growth
4.5.3. Contrast Enhanced Ultrasound Market Absolute $ Opportunity
5. Global Contrast Enhanced Ultrasound Market Analysis and Forecast by Types
5.1. Market Trends
5.2. Introduction
5.2.1. Basis Point Share (BPS) Analysis by Types
5.2.2. Y-o-Y Growth Projections by Types
5.3. Contrast Enhanced Ultrasound Market Size and Volume Forecast by Types
5.3.1. Non-targeted
5.3.2. Targeted
5.4. Absolute $ Opportunity Assessment by Types
5.5. Market Attractiveness/Growth Potential Analysis by Types
6. Global Contrast Enhanced Ultrasound Market Analysis and Forecast by Region
6.1. Market Trends
6.2. Introduction
6.2.1. Basis Point Share (BPS) Analysis by Region
6.2.2. Y-o-Y Growth Projections by Region
6.3. Contrast Enhanced Ultrasound Market Size and Volume Forecast by Region
6.3.1. North America
6.3.2. Latin America
6.3.3. Europe
6.3.4. Asia Pacific
6.3.5. Middle East and Africa (MEA)
6.4. Absolute $ Opportunity Assessment by Region
6.5. Market Attractiveness/Growth Potential Analysis by Region
6.6. Global Contrast Enhanced Ultrasound Demand Share Forecast, 2019-2026
7. North America Contrast Enhanced Ultrasound Market Analysis and Forecast
7.1. Introduction
7.1.1. Basis Point Share (BPS) Analysis by Country
7.1.2. Y-o-Y Growth Projections by Country
7.2. North America Contrast Enhanced Ultrasound Market Size and Volume Forecast by Country
7.2.1. U.S.
7.2.2. Canada
7.3. Absolute $ Opportunity Assessment by Country
7.4. North America Contrast Enhanced Ultrasound Market Size and Volume Forecast by Types
7.4.1. Non-targeted
7.4.2. Targeted
7.5. Basis Point Share (BPS) Analysis by Types
7.6. Y-o-Y Growth Projections by Types
7.7. Market Attractiveness/Growth Potential Analysis
7.7.1. By Country
7.7.2. By Product Type
7.7.3. By Application
7.8. North America Contrast Enhanced Ultrasound Demand Share Forecast, 2019-2026
8. Latin America Contrast Enhanced Ultrasound Market Analysis and Forecast
8.1. Introduction
8.1.1. Basis Point Share (BPS) Analysis by Country
8.1.2. Y-o-Y Growth Projections by Country
8.1.3. Latin America Average Pricing Analysis
8.2. Latin America Contrast Enhanced Ultrasound Market Size and Volume Forecast by Country
8.2.1. Brazil
8.2.2. Mexico
8.2.3. Rest of Latin America
8.3. Absolute $ Opportunity Assessment by Country
8.4. Latin America Contrast Enhanced Ultrasound Market Size and Volume Forecast by Types
8.4.1. Non-targeted
8.4.2. Targeted
8.5. Basis Point Share (BPS) Analysis by Types
8.6. Y-o-Y Growth Projections by Types
8.7. Market Attractiveness/Growth Potential Analysis
8.7.1. By Country
8.7.2. By Product Type
8.7.3. By Application
8.8. Latin America Contrast Enhanced Ultrasound Demand Share Forecast, 2019-2026
9. Europe Contrast Enhanced Ultrasound Market Analysis and Forecast
9.1. Introduction
9.1.1. Basis Point Share (BPS) Analysis by Country
9.1.2. Y-o-Y Growth Projections by Country
9.1.3. Europe Average Pricing Analysis
9.2. Europe Contrast Enhanced Ultrasound Market Size and Volume Forecast by Country
9.2.1. Germany
9.2.2. France
9.2.3. Italy
9.2.4. U.K.
9.2.5. Spain
9.2.6. Russia
9.2.7. Rest of Europe
9.3. Absolute $ Opportunity Assessment by Country
9.4. Europe Contrast Enhanced Ultrasound Market Size and Volume Forecast by Types
9.4.1. Non-targeted
9.4.2. Targeted
9.5. Basis Point Share (BPS) Analysis by Types
9.6. Y-o-Y Growth Projections by Types
9.7. Market Attractiveness/Growth Potential Analysis
9.7.1. By Country
9.7.2. By Product Type
9.7.3. By Application
9.8. Europe Contrast Enhanced Ultrasound Demand Share Forecast, 2019-2026
10. Asia Pacific Contrast Enhanced Ultrasound Market Analysis and Forecast
10.1. Introduction
10.1.1. Basis Point Share (BPS) Analysis by Country
10.1.2. Y-o-Y Growth Projections by Country
10.1.3. Asia Pacific Average Pricing Analysis
10.2. Asia Pacific Contrast Enhanced Ultrasound Market Size and Volume Forecast by Country
10.2.1. China
10.2.2. Japan
10.2.3. South Korea
10.2.4. India
10.2.5. Australia
10.2.6. Rest of Asia Pacific (APAC)
10.3. Absolute $ Opportunity Assessment by Country
10.4. Asia Pacific Contrast Enhanced Ultrasound Market Size and Volume Forecast by Types
10.4.1. Non-targeted
10.4.2. Targeted
10.5. Basis Point Share (BPS) Analysis by Types
10.6. Y-o-Y Growth Projections by Types
10.7. Market Attractiveness/Growth Potential Analysis
10.7.1. By Country
10.7.2. By Product Type
10.7.3. By Application
10.8. Asia Pacific Contrast Enhanced Ultrasound Demand Share Forecast, 2019-2026
11. Middle East & Africa Contrast Enhanced Ultrasound Market Analysis and Forecast
11.1. Introduction
11.1.1. Basis Point Share (BPS) Analysis by Country
11.1.2. Y-o-Y Growth Projections by Country
11.1.3. Middle East & Africa Average Pricing Analysis
11.2. Middle East & Africa Contrast Enhanced Ultrasound Market Size and Volume Forecast by Country
11.2.1. Saudi Arabia
11.2.2. South Africa
11.2.3. UAE
11.2.4. Rest of Middle East & Africa (MEA)
11.3. Absolute $ Opportunity Assessment by Country
11.4. Middle East & Africa Contrast Enhanced Ultrasound Market Size and Volume Forecast by Types
11.4.1. Non-targeted
11.4.2. Targeted
11.5. Basis Point Share (BPS) Analysis by Types
11.6. Y-o-Y Growth Projections by Types
11.7. Market Attractiveness/Growth Potential Analysis
11.7.1. By Country
11.7.2. By Product Type
11.7.3. By Application
11.8. Middle East & Africa Contrast Enhanced Ultrasound Demand Share Forecast, 2019-2026
12. Competition Landscape
12.1. Global Contrast Enhanced Ultrasound Market: Market Share Analysis
12.2. Contrast Enhanced Ultrasound Distributors and Customers
12.3. Contrast Enhanced Ultrasound Market: Competitive Dashboard
12.4. Company Profiles (Details: Overview, Financials, Developments, Strategy)
12.4.1. Siemens Healthcare Private Limited
12.4.2. Trivitron Healthcare
12.4.3. BK Medical Holding Company, Inc.
12.4.4. General Electric Company
12.4.5. Bracco Diagnostic Inc.
12.4.6. Bristol–Myers Squibb
12.4.7. Sonus Pharmaceuticals